Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Schizophrenia Linked To Dysfunction In Molecular Brain Pathway Activated By Marijuana

Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Expression of the cannabinoid 1 receptor (CB1R), the site of action of the main chemical ingredient of marijuana, is significantly reduced in the brains of individuals with schizophrenia. Activation of CB1R impairs signaling by gamma-aminobutyric acid (GABA), an important neurotransmitter essential for core cognitive processes such as working memory. The use of marijuana in individuals with schizophrenia appears to worsen this deficit in GABA synthesis.

Since reduced GABA is known to be present in schizophrenia, these findings suggest possible new drug targets that could help to improve function in people with the mental illness, University of Pittsburgh School of Medicine researchers report.

“Heavy marijuana use, particularly in adolescence, appears to be associated with an increased risk for the later development of schizophrenia, and the course of illness is worse for people with schizophrenia who use marijuana,” said David A. Lewis, M.D., corresponding author of the study and UPMC Endowed Professor in Translational Neuroscience, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine. “We wanted to understand the biological mechanisms that could explain these observations, and with this study, I believe that we can narrow down at least part of the ‘why’ to CB1R, the receptor for both tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana, and the brains own cannabinoid chemical messengers.”

Dr. Lewis and his colleagues examined specimens of brain tissue collected after death from 23 people with schizophrenia and 23 normal comparison subjects matched for a number of factors, including age and sex. The researchers evaluated levels of CB1R messenger RNA and protein, and also measured levels of glutamic acid decarboxylase (GAD-67), an enzyme that makes GABA, and cholecystokinin (CCK), a neuropeptide released from GABA neurons that, among other actions, regulates the production of the brain’s own cannabinoids.

“CB1R levels were significantly 15 percent lower in the subjects with schizophrenia,” Dr. Lewis said. “We measured these biochemical messengers using three techniques, and each time got the same answer – less CB1R in people with schizophrenia.” This reduction, he noted, appears to be the brain’s way of compensating for lower levels of GABA, and the use of marijuana defeats this compensation.

“These findings may provide insight into the biological basis of why cannabis use worsens schizophrenia, and, as a result, identify a novel target for new drug development that could improve treatments available for schizophrenia,” said Dr. Lewis.

Other authors include Stephen M. Eggan, Ph.D., and Takanori Hashimoto, M.D., Ph.D., both of the Department of Psychiatry, University of Pittsburgh School of Medicine.

The study was funded by the National Institutes of Health. Additional funding support for Dr. Eggan came from the University of Pittsburgh’s Andrew Mellon Predoctoral and Scottish Rite fellowships.

source: University of Pittsburgh Medical Center

More Treatment & Detox Articles

Governments’ Drug-Abuse Costs Hit $468 Billion, Study Says

Government spending related to smoking and the abuse of alcohol and illegal drugs reached $468 billion in 2005, accounting for more than one-tenth of combined federal, state and local expenditures for all purposes, according to a new study. Most abuse-related spending went toward direct health care costs for lung disease, cirrhosis and overdoses, for example,….

Study blames alcohol for half 1990s Russian deaths

A new study by an international team of public health researchers documents the devastating impact of alcohol abuse on Russia — showing that drinking caused more than half of deaths among Russians aged 15 to 54 in the turbulent era following the Soviet collapse. The 52 percent figure compares to estimates that less than 4….

NY reforms treatment of addiction, mental illness

The vast majority of New Yorkers struggling both with mental illness and substance abuse don’t get treatment for both conditions at the same time – a barrier that can result in relapse, discontinued treatment and, in some cases, suicide. It’s a problem that’s gone on for years because of a flawed Medicaid coding system, and….

Overeaters Anonymous provides support in fight against compulsion

FRAMINGHAM, Mass. — Facing a dozen strangers seated around a table, the heavyset man with thinning hair put down his coffee and paused before introducing himself: “My name is Christian. And I’m a compulsive overeater.” For the next hour, members of the MetroWest Intergroup of Overeaters Anonymous shared personal stories of long-term weight gain and….

Types of Treatment at Methadone Treatment Centers

Abuse of prescription pain medications and street drugs, such as heroin and opium has left many recreational users at the mercy of an addiction. Also known as opiate or narcotic drugs, battling this type of addiction requires specialized medical treatment along with ongoing support and guidance. Methadone treatment centers specialize in treating opiate addictions using….